Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
12,683
datasets available to search
ShareScore release 0.9.0
Dataset results
12,683 results for “tolerability”
Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT03276078. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation R
ClinicalTrials.gov study NCT02222610. IPD Sharing: NO. Countries: 1. Publications: 21.
A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants
ClinicalTrials.gov study NCT02093923. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis
ClinicalTrials.gov study NCT02776033. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults
ClinicalTrials.gov study NCT02114268. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID
ClinicalTrials.gov study NCT01175213. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
ClinicalTrials.gov study NCT03210961. IPD Sharing: NO. Countries: 1. Publications: 1.
Immune Tolerance Induction After Liver Transplantation
ClinicalTrials.gov study NCT07269041. IPD Sharing: NO. Countries: 1. Publications: 2.
Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB2 in Healthy Subjects
ClinicalTrials.gov study NCT01922336. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants
ClinicalTrials.gov study NCT02219256. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine
ClinicalTrials.gov study NCT02873221. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies
ClinicalTrials.gov study NCT01830010. IPD Sharing: UNDECIDED. Countries: 3. Publications: 1.
Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.
ClinicalTrials.gov study NCT04126031. IPD Sharing: YES. Countries: 8. Publications: 1.
Safety and Tolerability of Antiplaque Chewing Gum in a Gingivitis Population
ClinicalTrials.gov study NCT01877421. IPD Sharing: NO. Countries: 1. Publications: 1.
A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants
ClinicalTrials.gov study NCT05184452. IPD Sharing: NO. Countries: 4. Publications: 1.
A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children
ClinicalTrials.gov study NCT04816643. IPD Sharing: NO. Countries: 6. Publications: 4.
Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension
ClinicalTrials.gov study NCT02639286. IPD Sharing: NO. Countries: 1. Publications: 5.
Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)
ClinicalTrials.gov study NCT03969901. IPD Sharing: YES. Countries: 18. Publications: 0.
Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance
ClinicalTrials.gov study NCT02621060. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms
ClinicalTrials.gov study NCT04407507. IPD Sharing: Not stated. Countries: 1. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.